CTNNA2
protein-codingcatenin alpha 2, the group of Alpha catenins
Gene summary
Enables actin filament binding activity. Involved in negative regulation of Arp2/3 complex-mediated actin nucleation; regulation of neuron migration; and regulation of neuron projection development. Located in cytoplasm. Implicated in complex cortical dysplasia with other brain malformations 9. [provided by Alliance of Genome Resources, Jun 2026]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~1,463.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032578
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0032578
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0032578
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CTNNA2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001282597.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 25 | 4 | 30 | ||
| missense | 78 | 1 | 1 | 80 | ||
| nonsense | 3 | 1 | 2 | 6 | ||
| start loss | 0 | |||||
| frameshift | 1 | 3 | 1 | 5 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 5 | 4 | 83 | 26 | 5 | 123 |
Highest pathogenic variant AF is 0.0000065731524
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001269526.1 | 18 | MANE Select | |
| Ensembl | ENSP00000384638.4 | 18 | MANE Select | |
| RefSeq | NP_001158355.1 | 16 | Standard | |
| RefSeq | NP_001269527.1 | 18 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Gastric cancer - Homo sapiens (human)
- Adherens junction - Homo sapiens (human)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human)
- Hippo signaling pathway - Homo sapiens (human)
- Bacterial invasion of epithelial cells - Homo sapiens (human)
Biological Process
- cytoskeleton organization
- axonogenesis
- radial glia guided migration of Purkinje cell
- dendrite morphogenesis
- brain morphogenesis
Molecular Function
- structural constituent of cytoskeleton
- protein binding
- identical protein binding
- cadherin binding
- actin filament binding
Cellular Component
- nucleus
- cytoplasm
- cytosol
- adherens junction
- cell-cell adherens junction
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000466387
- Coding exons
- 17
- Length
- 1463549
- Individuals with no LoFs
- 125264
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 21
- Defined
- 125285
- p
- 0.0000838
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.63 | 306 | 544 | 0.562 | 0.0000329 | 5931 |
| Missense (PolyPhen) | 72 | 158.38 | 0.45461 | 1732 | ||
| Synonymous | -0.223 | 221 | 217 | 1.02 | 0.0000144 | 1775 |
| Loss of Function | 4.82 | 10 | 44.8 | 0.223 | 0.00000263 | 496 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00013 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000062 | 0.000062 | rare |
| South Asian | 0.00029 | 0.00029 | rare |
| Other | 0.00017 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May function as a linker between cadherin adhesion receptors and the cytoskeleton to regulate cell-cell adhesion and differentiation in the nervous system. Regulates morphological plasticity of synapses and cerebellar and hippocampal lamination during development. Functions in the control of startle modulation. {ECO:0000250|UniProtKB:Q61301}.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- LoFtool
- 0.502
- RVIS EVS
- -0.64
- RVIS percentile EVS
- 16.63
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.275
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |